Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: Pharmacogenomics J. 2015 Oct 27;17(1):36–41. doi: 10.1038/tpj.2015.77

Table 2.

Baseline clinical characteristics of Japanese and LAC patient cohorts

Japanese (N = 169)
LAC (N = 172)
P-valuea
N % N %
Gender
 Male 109 64 115 67 0.65
 Female 60 36 57 33
Age (year)
 Median (range) 67 (31–88) 61 (26–74) < 0.001
 < 65 65 38 101 59 < 0.001
 ⩾ 65 104 62 71 41
Stage
 I – II 81 48 84 49 0.34
 III–IV 88 52 74 43
 Unknownb 14 8
T-category
 T1 – T2 78 46 54 31 0.017
 T3 – T4 91 54 108 63
 Unknownb 10 6
N-category
 N0 – N1 121 72 82 48 0.003
 N2 – N3 48 28 66 38
 Unknownb 24 14
Primary tumor site
 Proximal 46 27 77 45 < 0.001
 Distal 123 73 95 55
Tumor differentiation
 Differentiated 68 40 44 26 0.018
 Undifferentiated 101 60 114 66
 Unknownb 14 8
Ethnicity
 Asian 169 100 30 17 NA
 Caucasian 90 52
 Hispanic 38 22
 African American 14 8
a

Based on χ2-test or Wilcoxon test, whichever was appropriate.

b

Excluded in χ2-test.